ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

Cancer Information Service facing $6 million cut, consolidation. Also Give NIH director greater authority, budget; review NCI’s special status, IOM says.

August 1, 2003

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012